[go: up one dir, main page]

IN2014DE02197A - - Google Patents

Download PDF

Info

Publication number
IN2014DE02197A
IN2014DE02197A IN2197DE2014A IN2014DE02197A IN 2014DE02197 A IN2014DE02197 A IN 2014DE02197A IN 2197DE2014 A IN2197DE2014 A IN 2197DE2014A IN 2014DE02197 A IN2014DE02197 A IN 2014DE02197A
Authority
IN
India
Prior art keywords
hot
melt
hpmcas
drug
melt extrusion
Prior art date
Application number
Other languages
English (en)
Inventor
Naosuke Maruyama
Shogo Warashina
Fumie Kusaki
Sakae Obara
Kazuki Kikuchi
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51225402&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DE02197(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2014DE02197A publication Critical patent/IN2014DE02197A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IN2197DE2014 2013-08-12 2014-08-01 IN2014DE02197A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013167572 2013-08-12

Publications (1)

Publication Number Publication Date
IN2014DE02197A true IN2014DE02197A (fr) 2015-06-19

Family

ID=51225402

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2197DE2014 IN2014DE02197A (fr) 2013-08-12 2014-08-01

Country Status (6)

Country Link
US (1) US11090295B2 (fr)
EP (1) EP2837391B1 (fr)
JP (1) JP6162662B2 (fr)
KR (1) KR102089112B1 (fr)
CN (1) CN104371030B (fr)
IN (1) IN2014DE02197A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6203702B2 (ja) * 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
US10604588B2 (en) 2016-04-05 2020-03-31 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate powder excellent in dissolved state and production method thereof, and production methods for composition for solid dispersion, coating composition, drug-containing particle, and solid preparation
WO2017032908A1 (fr) * 2016-07-08 2017-03-02 Synthon B.V. Composition pharmaceutique comprenant du posaconazole amorphe
JP6683561B2 (ja) * 2016-07-12 2020-04-22 信越化学工業株式会社 腸溶性硬カプセル用組成物及び腸溶性硬カプセルの製造方法
JP6742197B2 (ja) * 2016-08-29 2020-08-19 信越化学工業株式会社 ヒプロメロースフタル酸エステルの製造方法
JP6644656B2 (ja) * 2016-08-29 2020-02-12 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルの製造方法
US20190038754A1 (en) 2017-08-07 2019-02-07 SE Tylose, USA, Inc. Pharmaceutical composition in solid extruded form
TR201722852A2 (tr) * 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari
JP6905035B2 (ja) * 2019-11-29 2021-07-21 Nissha株式会社 可食性フィルムの製造方法、フィルム製剤及び可食性フィルム
JP7399061B2 (ja) * 2020-10-01 2023-12-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースフタレートの製造方法
EP4497760A1 (fr) * 2023-07-26 2025-01-29 Shin-Etsu Chemical Co., Ltd. Poudre d'acétate succinate d'hydroxypropylméthylcellulose et son procédé de production
CN120938940A (zh) * 2025-10-15 2025-11-14 成都药宜立康医药科技有限公司 一种苯磺酸美洛加巴林药物组合物及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
JPS5951562B2 (ja) 1977-10-25 1984-12-14 信越化学工業株式会社 セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JP2528706B2 (ja) 1988-05-30 1996-08-28 ゼリア新薬工業株式会社 ジヒドロピリジン化合物の製剤組成物
JP2925346B2 (ja) 1991-03-18 1999-07-28 田辺製薬株式会社 腸溶性製剤およびその製法
JP2527107B2 (ja) 1991-04-16 1996-08-21 日本新薬株式会社 固体分散体の製造方法
JPH0920663A (ja) * 1995-07-07 1997-01-21 Teikoku Seiyaku Co Ltd イブジラストを含有する徐放性細粒剤およびその製法
JP4290817B2 (ja) 1999-07-29 2009-07-08 株式会社金門製作所 ガスメータ
ATE279186T1 (de) * 1999-08-31 2004-10-15 Gruenenthal Gmbh Retardierte darreichungsform enthaltend tramadolsaccharinat
EP2415462A1 (fr) 1999-12-23 2012-02-08 Mayne Pharma International Pty Ltd. Compositions pharmaceutiques ameliorées pour médicaments peu solubles
JP3552160B2 (ja) * 2000-01-14 2004-08-11 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粒子の形成方法
JPWO2003077827A1 (ja) 2002-03-19 2005-07-14 日本新薬株式会社 医薬固体分散体の製造方法
KR100454394B1 (ko) 2002-03-27 2004-10-26 이원희 맥파검출장치
GB0418791D0 (en) 2004-08-23 2004-09-22 Glaxo Group Ltd Novel process
JP2007308480A (ja) * 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 腸溶性固体分散体を含んでなる固形製剤
JP5576922B2 (ja) * 2006-04-20 2014-08-20 信越化学工業株式会社 腸溶性固体分散体を含んでなる固形製剤
CN101121755B (zh) * 2006-08-08 2012-04-11 信越化学工业株式会社 低取代羟丙基纤维素粉末及其制备方法
CN101702878B (zh) * 2007-05-11 2012-11-28 弗·哈夫曼-拉罗切有限公司 可溶性差的药物的药物组合物
JP2009089982A (ja) * 2007-10-11 2009-04-30 Ohara Yakuhin Kogyo Kk 打錠用造粒物の造粒方法
NZ588460A (en) 2008-04-15 2012-07-27 Schering Corp Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
EP2278957A2 (fr) 2008-04-15 2011-02-02 Schering Corporation Compositions pharmaceutiques orales comprenant une dispersion solide contenant préférablement du posaconazole et un hpmcas
WO2009132208A1 (fr) 2008-04-24 2009-10-29 Evestra, Inc. Formes galéniques contraceptives orales renfermant un progestogène dispersé dans un polymère gastrorésistant et renfermant en outre un œstrogène
CN102988318A (zh) 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
AU2010232670B2 (en) * 2009-04-03 2015-07-09 F. Hoffmann-La Roche Ag Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
JP5324302B2 (ja) * 2009-04-22 2013-10-23 信越化学工業株式会社 高成型性、高流動性低置換度ヒドロキシプロピルセルロースおよびそれを含む固形製剤
FR2945947B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
PT2647648T (pt) 2010-12-03 2017-10-02 Nippon Soda Co Forma de dosagem sólida que contém uma hidroxialquil celulose de baixa viscosidade
AU2012225459A1 (en) 2011-03-08 2013-10-10 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
EP2694110B2 (fr) 2011-04-06 2022-06-08 Dow Global Technologies LLC Nouveau composes polysaccharides et préparations pharmaceutiques
EP2524688B1 (fr) 2011-05-11 2013-05-01 ratiopharm GmbH Composition de libération modifiée comportant de la ranolazine
CN103083240B (zh) * 2011-10-28 2015-12-09 沈阳药科大学 紫杉醇及其同系物的固体分散体及其口服制剂的制备

Also Published As

Publication number Publication date
EP2837391B1 (fr) 2017-05-10
KR102089112B1 (ko) 2020-03-13
JP2015057380A (ja) 2015-03-26
KR20150020073A (ko) 2015-02-25
CN104371030A (zh) 2015-02-25
CN104371030B (zh) 2017-08-08
US11090295B2 (en) 2021-08-17
US20150044289A1 (en) 2015-02-12
EP2837391A1 (fr) 2015-02-18
JP6162662B2 (ja) 2017-07-12

Similar Documents

Publication Publication Date Title
IN2014DE02197A (fr)
IN2014DE01467A (fr)
GB2573445A (en) Cemented carbide powders for additive manufacturing
WO2012021504A3 (fr) Composition de tabac sans fumée fusible
PH12017500894A1 (en) Surface-treated compacted material
WO2012106149A3 (fr) Membrane métallique poreuse en poudres frittées et fibres métalliques
GB2486973B (en) High density polycrystalline superhard material
EP3053880A4 (fr) Procédé pour contrôler la masse volumique apparente d'agglomérat de nanotubes de carbone
WO2014165310A3 (fr) Distribution de poudre améliorée pour systèmes de frittage par laser
CL2014002037A1 (es) Material mineral en polvo con elevada capacidad de dispersión, y uso de dicho material mineral en polvo
WO2015017478A3 (fr) Synthèse de nanofils semi-conducteur cœur/enveloppe cdse/zns
EP3102609A4 (fr) Méthodes de production de lymphocytes t autologues utilisés pour traiter les tumeurs malignes à lymphocytes b et d'autres cancers, et compositions associées
EP3042925A4 (fr) Procédé pour produire des particules poreuses de cellulose et particules poreuses de cellulose
MX2015012353A (es) Aparatos, sistemas y metodos asociados para la formacion de masas porosas organicas para filtros de humo de sabor.
TWI563713B (en) Conducting material composition, and slurry composition for forming electrode of lithium rechargeable battery and lithium rechargeable battery using the same
EP3021328A4 (fr) Composition de pâte de céramique au moyen d'un nanotube de carbone ou d'un complexe nanotube de carbone-métal et film conducteur la contenant
EP3039743A4 (fr) Batterie à semi-conducteurs à accélérateur de vitesse intégré
PL2999759T3 (pl) Kompozycja spoiwa do elektrody i sposoby jej wytwarzania
MX339803B (es) Composicion para cuerpos moldeados por extrusion.
EP3030614A4 (fr) Mélange de polymères, article multicouche contenant celui-ci, et procédé de préparation de l'article multicouche
EP3081966A4 (fr) Composition polymérisable pour matériaux optiques, matériau optique et son procédé de production
MY173731A (en) Method for preparing a sorbent
WO2015102732A3 (fr) Mélange-maître contenant un alliage amorphe pour moulage par injection de poudre
SG10201811365RA (en) Slow-release conjugates of sn-38
WO2013045944A3 (fr) Élément fumable